Skip to Main Content

Author Details

Peiwen Lu
Yale University School of Medicine
2013
28
19
Wade Schulz (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37871202Developing synthetic tools to decipher the tumor-immune interactome.Proc Natl Acad Sci U S A2023
37748514Distinguishing features of long COVID identified through immune profiling.Nature2023
34718647Longitudinal Immune Profiling of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection in a Solid Organ Transplant Recipient.J Infect Dis2022
35768006Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.Cell2022
35043113Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain.bioRxiv2022
35217624Lack of association between pandemic chilblains and SARS-CoV-2 infection.Proc Natl Acad Sci U S A2022
35058919Endogenous Retroviruses Provide Protection Against Vaginal HSV-2 Disease.Front Immunol2022
35301314De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report.Nat Commun2022
33433624Neuroinvasion of SARS-CoV-2 in human and mouse brain.J Exp Med2021
35373072Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients.Kidney3602021
34909781<i>De novo</i> emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report.medRxiv2021
34145437Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19.Nat Med2021
32122994Cutting Edge: The Use of Topical Aminoglycosides as an Effective Pull in "Prime and Pull" Vaccine Strategy.J Immunol2020
33398304Kinetics of antibody responses dictate COVID-19 outcome.medRxiv2020
32577695Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes.medRxiv2020
32577647Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.bioRxiv2020
32714125Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.SSRN2020
32857487Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2.N Engl J Med2020
32935108Neuroinvasion of SARS-CoV-2 in human and mouse brain.bioRxiv2020
32846427Sex differences in immune responses that underlie COVID-19 disease outcomes.Nature2020
32750141Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.J Exp Med2020
31189952Migrant memory B cells secrete luminal antibody in the vagina.Nature2019
31396405Successful application of prime and pull strategy for a therapeutic HSV vaccine.NPJ Vaccines2019
28650481Germinal-center development of memory B cells driven by IL-9 from follicular helper T cells.Nat Immunol2017
28408722Ephrin B1-mediated repulsion and signaling control germinal center T cell territoriality and function.Science2017
24145857Follicular T-helper cells: controlled localization and cellular interactions.Immunol Cell Biol2014
24369347Identification of a new isoform of the murine Sh2d1a gene and its functional implications.Sci China Life Sci2014
23812097MicroRNAs of the miR-17⿼92 family are critical regulators of T(FH) differentiation.Nat Immunol2013
  • 1 - 28 of 28

Recommended Authors

Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2016
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 2015
Number of shared co-authors 0
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR 9
Career Start Year 2012
Number of shared co-authors 0
Karolinska Institute, Center for Molecular Medicine
Career Start Year 2012
Number of shared co-authors 0
University of Alabama at Birmingham Birmingham
Career Start Year 2011
Number of shared co-authors 0
University of Maryland
Career Start Year 2010
Number of shared co-authors 0
Sorbonne University INSERM
Career Start Year 2010
Number of shared co-authors 0
University of Illinois at Chicago
Career Start Year 2008
Number of shared co-authors 0
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 1
Stanford University
Career Start Year 2005
Number of shared co-authors 2
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Career Start Year 2005
Number of shared co-authors 0
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinaigrid.59734.3c
Career Start Year 2004
Number of shared co-authors 0
Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 3
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 1
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 1
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 0
University of California San Diego
Career Start Year 1999
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1998
Number of shared co-authors 0
Institute of Immunity, Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 2
National Institute of Allergy and Infectious Diseases
Career Start Year 1995
Number of shared co-authors 0
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year 1990
Number of shared co-authors 1
University of Michigan Medical School
Career Start Year 1989
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 1
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 1973
Number of shared co-authors 1

Collaborators

Yale University
Co-authored papers 20
Yale University School of Medicine
Co-authored papers 15
Yale University School of Medicine
Co-authored papers 13
Yale University
Co-authored papers 10
Yale University School of Medicine
Co-authored papers 10
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers 10
Yale School of Medicine
Co-authored papers 9
Department of Microbial Pathogenesis Yale University New Haven
Co-authored papers 8
Yale School of Public Health
Co-authored papers 7
Yale University School of Medicine
Co-authored papers 7
Yale School of Medicine
Co-authored papers 7
School of Public Health, Yale University
Co-authored papers 7
Yale School of Public Health
Co-authored papers 7
Yale School of Public Health
Co-authored papers 7
Yale School of Public Health
Co-authored papers 7
Yale School of Medicine
Co-authored papers 7
College of Science & Industry Convergence, Ewha Womans University
Co-authored papers 6
Christian Medical College
Co-authored papers 6
Yale School of Medicine
Co-authored papers 6
Yale School of Public Health
Co-authored papers 5
Yale University
Co-authored papers 5
Yale School of Public Health
Co-authored papers 5
Yale School of Public Health
Co-authored papers 4
Co-authored papers 3
Yale University School of Medicine
Co-authored papers 3
Yale School of Medicine, Yale University
Co-authored papers 3
Emory University School of Medicine
Co-authored papers 3
Dalla Lana School of Public Health, University of Toronto
Co-authored papers 2
Yale University, USA Howard Hughes Medical Institute
Co-authored papers 2
Boyer Center for Molecular Medicine, Yale University
Co-authored papers 2